1-3 of 3
Mario Regazzi Bonora
Close
Sort by
Journal Articles

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Arcangelo Prete, MD, Antonella Bartoli, MD, Claudia Castellini, MD, Roberto Rondelli, MD, Riccardo Masetti, MD, Andrea Pession, MD, Mario Regazzi-Bonora, MD
Journal: Blood
Blood (2005) 106 (11): 5320.
https://doi.org/10.1182/blood.V106.11.5320.5320
Published: 2005
Journal Articles

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial

Clinical Trials & Observations
Franco Locatelli, Peter Nöllke, Marco Zecca, Elisabeth Korthof, Edoardo Lanino, Christina Peters, Andrea Pession, Hartmut Kabisch, Cornelio Uderzo, Carmen S. Bonfim, Peter Bader, Dagmar Dilloo, Jan Stary, Alexandra Fischer, Tom Révész, Monika Führer, Henrik Hasle, Monika Trebo, Marry M. van den Heuvel-Eibrink, Susanna Fenu, Brigitte Strahm, Giovanna Giorgiani, Mario Regazzi Bonora, Ulrich Duffner, Charlotte M. Niemeyer, on behalf of the European Working Group on Childhood MDS (EWOG-MDS) and the European Blood and Marrow Transplantation (EBMT) Group
Journal: Blood
Blood (2005) 105 (1): 410–419.
https://doi.org/10.1182/blood-2004-05-1944
Published: 2005
Journal Articles

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

Clinical Trials & Observations
Marco Zecca, Bruno Nobili, Ugo Ramenghi, Silverio Perrotta, Giovanni Amendola, Pasquale Rosito, Momcilo Jankovic, Paolo Pierani, Piero De Stefano, Mario Regazzi Bonora, Franco Locatelli
Journal: Blood
Blood (2003) 101 (10): 3857–3861.
https://doi.org/10.1182/blood-2002-11-3547
Published: 2003